Pyrimethamine contraindications

Revision as of 21:16, 9 January 2014 by Chetan Lokhande (talk | contribs) (Created page with "__NOTOC__ {{Pyrimethamine}} {{CMG}}; {{AE}} {{chetan}} ==Contraindications== Use of DARAPRIM is contraindicated in patients with known hypersensitivity to pyrimethamine ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Pyrimethamine
DARAPRIM® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Contraindications

Use of DARAPRIM is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. Use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.[1]

References

  1. "DARAPRIM (PYRIMETHAMINE) TABLET [AMEDRA PHARMACEUTICALS LLC]".

Adapted from the FDA Package Insert.